首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1630773

急性胰臟炎市場規模、佔有率和成長分析（按診斷、原因、治療、最終用戶和地區）- 產業預測 2025-2032

Acute Pancreatitis Market Size, Share, Growth Analysis, By Diagnosis (Imaging Tests, Laboratory Tests), By Cause (Gallstones, Alcohol), By Treatment, By End user, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月09日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球急性胰臟炎市場規模預計將在 2023 年達到 58 億美元，從 2024 年的 61.4 億美元成長到 2032 年的 97.2 億美元，預測期內（2025-2032 年）的複合年成長率為 5.9%。

受病例數量的增加和醫療治療的重大進步的推動，全球急性胰臟炎市場正在迅速發展。嚴重的胰臟炎會帶來嚴重的健康風險，推動對有效的診斷、治療和管理解決方案的需求。主要的市場促進因素包括因肥胖、飲酒和膽結石等風險因素導致的盛行率增加、診斷技術的改進和新的治療方案。這是一個競爭激烈的領域，製藥公司、醫療設備製造商和醫療保健提供者積極進行研究、臨床試驗和策略聯盟，以增強其產品供應。持續的創新和合作預計將塑造市場的未來，旨在改善患者的治療效果並解決與這種嚴重健康狀況相關的複雜問題。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益與前一年同期比較（2022-2024 年）

主要企業簡介

Pfizer Inc.（United States）
Merck & Co., Inc.（United States）
Baxter International Inc.（United States）
Abbott Laboratories（United States）
B. Braun SE（Germany）
CalciMedica Inc.（United States）
Dynavax Technologies Corporation（United States）
Fresenius SE & Co. KGaA（Germany）
GlaxoSmithKline plc（United Kingdom）
Olympus Corporation（Japan）
SCM Lifescience（South Korea）
Samsung Bioepis（South Korea）
GNT Pharma Co.（South Korea）
Medtronic plc（Ireland）
Boston Scientific Corporation（United States）
Takeda Pharmaceuticals（Japan）
Novartis AG（Switzerland）
AbbVie Inc.（United States）
General Electric Company（United States）
Mitsubishi Tanabe Pharma Corporation（Japan）

結論和建議

簡介目錄

Product Code: SQMIG35D2197

Global Acute Pancreatitis Market size was valued at USD 5.8 billion in 2023 and is poised to grow from USD 6.14 billion in 2024 to USD 9.72 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).

The global acute pancreatitis market is evolving rapidly, fueled by rising case numbers and significant medical advancements. This severe pancreatic inflammation poses serious health risks, resulting in a growing demand for effective diagnosis, treatment, and management solutions. Key market drivers include increased prevalence attributed to risk factors like obesity, alcohol consumption, and gallstones, alongside improvements in diagnostic technologies and novel therapeutic options. The sector is highly competitive, with pharmaceutical firms, medical device manufacturers, and healthcare providers actively engaged in research, clinical trials, and strategic alliances to enhance their offerings. Continuous innovation and collaboration are anticipated to shape the market's future, aiming to improve patient outcomes and address the complexities associated with this critical health condition.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Acute Pancreatitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Acute Pancreatitis Market Segmental Analysis

Global Acute Pancreatitis Market is segmented by Diagnosis, Cause, Treatment, End user and region. Based on Diagnosis, the market is segmented into Imaging Tests and Laboratory Tests. Based on Cause, the market is segmented into Gallstones, Alcohol and Others. Based on Treatment, the market is segmented into Intravenous fluid, Nutritional support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP) and Others. Based on End user, the market is segmented into Hospitals, Clinics, Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Acute Pancreatitis Market

The Global Acute Pancreatitis market is expected to experience significant growth driven by the rising prevalence of diabetes, which can be exacerbated by pancreatitis as it damages insulin-producing cells in the pancreas. Approximately 45% of individuals with chronic pancreatitis eventually develop diabetes, highlighting a crucial link between these conditions. Furthermore, the market is supported by an aging population and proactive government initiatives aimed at enhancing awareness and education regarding pancreatic health. Additionally, changing consumer lifestyles, increasing obesity rates, and the potential rise in pancreatic cancer cases will further contribute to the expansion of the Acute Pancreatitis market.

Restraints in the Global Acute Pancreatitis Market

The Global Acute Pancreatitis market faces several significant restraints that may hinder its growth. One of the primary challenges is the high cost associated with treatment, which can limit accessibility for patients. Furthermore, developing economies may struggle with inadequate healthcare infrastructure, complicating treatment access and reducing market expansion potential. Additionally, a stringent regulatory environment adds another layer of complexity, while poor reimbursement practices deter patients from seeking necessary care. Lastly, a lack of public awareness about Acute Pancreatitis further stifles market growth, as it reduces the urgency for innovative treatments and interventions. These factors collectively contribute to a slow market development trajectory.

Market Trends of the Global Acute Pancreatitis Market

The global acute pancreatitis market is currently experiencing notable trends that emphasize early diagnosis and personalized treatment strategies. Increased investment in advanced diagnostic technologies aims to facilitate the swift identification of acute pancreatitis, allowing for timely therapeutic intervention and reduced complication rates. Furthermore, there is a rising inclination towards precision medicine, driven by advancements in genetic profiling and molecular diagnostics that allow for customized treatment plans. Additionally, the integration of digital health solutions is revolutionizing patient management and monitoring. Collectively, these trends are driving innovation in therapies, improving patient outcomes, and enhancing overall care in the acute pancreatitis landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Acute Pancreatitis Market Size by Diagnosis & CAGR (2025-2032)

Market Overview
Imaging Tests
Laboratory Tests

Global Acute Pancreatitis Market Size by Cause & CAGR (2025-2032)

Market Overview
Gallstones
Alcohol
Others

Global Acute Pancreatitis Market Size by Treatment & CAGR (2025-2032)

Market Overview
Intravenous fluid
Nutritional support
Analgesics
Endoscopic Retrograde Cholangiopancreatography (ERCP)
Others

Global Acute Pancreatitis Market Size by End user & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Diagnostic Centers
Others

Global Acute Pancreatitis Market Size & CAGR (2025-2032)

North America (Diagnosis, Cause, Treatment, End user)
- US
- Canada
Europe (Diagnosis, Cause, Treatment, End user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Diagnosis, Cause, Treatment, End user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Diagnosis, Cause, Treatment, End user)
- Brazil
- Rest of Latin America
Middle East & Africa (Diagnosis, Cause, Treatment, End user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CalciMedica Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dynavax Technologies Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SCM Lifescience (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Samsung Bioepis (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GNT Pharma Co. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceuticals (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Tanabe Pharma Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments